Compare iShares US Power Infrastructure ETF (POWR) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares US Power Infrastructure ETF vs Regeneron Pharmaceuticals Inc — how do they compare? iShares US Power Infrastructure ETF trades at $25.47 (market cap $446.54M), while Regeneron Pharmaceuticals Inc trades at $746.54 (market cap $76.14B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 170.5× iShares US Power Infrastructure ETF's market cap, and Regeneron Pharmaceuticals Inc pays a 0.51% dividend while iShares US Power Infrastructure ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares US Power Infrastructure ETF for 14 Days and Regeneron Pharmaceuticals Inc for 107 Days on average.
| POWR | REGN | |
|---|---|---|
Market Cap | $446.54M | $76.14B |
Volume | 160,852 | 500,239 |
Sector | Sector/Thematic | Health |
52-Week High | $28.22 | $852.03 |
52-Week Low | $23.20 | $557.73 |
Typical Hold Time | 14 Days | 107 Days |
Enterprise Value | — | $70.85B |
Dividend Yield | — | 0.51% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Regeneron Pharmaceuticals (REGN) trades at $739.57, down 0.34% on the day, with a bearish technical signal from moving averages. The company maintains strong fundamentals, including a 27.86% net income margin and consistent earnings beats. Recent news highlights a significant immunology alliance expansion with Sanofi, valued up to $8 billion, which could drive future growth. Cash flow improved in 2025, with net cash flow turning positive at $634.70 million.
The outlook is positive, supported by robust profitability and strategic collaborations, but faces risks from competition in key drug markets and reliance on pipeline success. Analysts are bullish with a consensus price target of $849.84, implying potential upside. Investors should weigh strong financials against execution risks in drug development.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares US Power Infrastructure ETF
iShares U.S. Power Infrastructure ETF seeks exposure to U.S. companies involved in power infrastructure. Its holdings may include electric utilities, transmission and distribution businesses, and electrical equipment providers.
Read more on POWR →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
